SYK: Symmetrical Triangle detected on 26 Jun 2026

Stryker forms a symmetrical triangle consolidating between $304.81 support and $309.66 resistance near $316.11. The pattern exhibits strong structure (13.0/15) and breakout quality (13.0/13), balanced by moderate volume momentum (8.0/12). The 63.65% win probability and bullish market regime (0.95 score) favor continuation, though the volume ratio of 0.87 suggests some caution about confirmation strength into the actual breakout move.

Stryker delivered strong 2025 results with $25.1 billion in revenue and entered 2026 with significant momentum. Q1 2026 showed adjusted EPS of $2.60, down 8.5% due to a cyber incident recovery period. Management reaffirmed full-year guidance despite the Q1 disruption and announced a restructuring combining orthopaedic instruments with Mako robotics into a new Ortho Tech business to accelerate innovation. The cyberattack disrupted operations in Q1 2026, though the underlying business momentum remains intact. The stock has faced headwinds with a 17.6% decline over the past year, attributed partly to the cyberattack and lower utilization rates. The pattern reflects post-disruption stabilization as the company demonstrates operational recovery.

A successful breakout above $309.66 resistance would target $330.45 on the conservative measure—a 4.6% move from current levels. The pattern's 63.65% historical win probability reflects moderate confidence in breakout execution. Invalidation occurs below the $304.81 support level, which would signal pattern failure and suggest renewed weakness. Volume confirmation remains critical: the current 0.87 relative volume ratio means the breakout requires elevated institutional participation to validate the triangle resolution.

Stryker disclosed an ongoing cyber incident investigation with potential for further financial, reputational, and operational impacts, including business interruption, revenue loss, and increased cybersecurity expenditures. Lower hospital utilization rates are pressuring demand. With RSI at 55.71 (neutral), there is room to move higher without overbought warning. However, the 2.74% ATR volatility is compressed, and the low beta (0.52) suggests this setup relies on company-specific catalysts rather than broad market momentum. Q2 2026 results will be critical; any margin disappointment or slower-than-expected recovery from the cyberattack could trigger a breakdown below support.

We scan more than 6,000 NYSE and NASDAQ stocks every trading day and compare each detected pattern against a database of 370,000+ historical detections. Every setup is scored across three dimensions: Structure, Volume, and Breakout Readiness. Win probability is a calibrated estimate of how similar historical setups performed over the following 10 trading days. This is a swing trading tool built for multi-day holds. It is not built or tested for day trading.